Live Evaluations
2023 Fall Clinical Dermatology Conference for PAs and NPs
About
Learning Objectives
At the completion of this activity, participants should be better able to:
Discuss the pathogenesis and optimal management of psoriasis, atopic dermatitis and acne vulgaris
Update knowledge regarding recent advances in the safe and effective use of biologic agents for the treatment of dermatologic diseases
Enhance the ability to evaluate and incorporate new techniques and uses of dermal fillers and neurotoxins
Identify and describe the indications, contraindications, and evidence-based safety and efficacy profiles of new agents approved for use in the dermatology setting Integrate prevention, diagnosis, and management of skin cancer into my clinical setting
Diagnose commonly presented dermatologic disorders
Improve my clinical interactions with patients
Integrate knowledge to enhance daily dermatologic care
Intended Audience
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada and CMEsquared. The University of Nevada is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada designates this enduring activity for a maximum of 11 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
CONFLICTS OF INTEREST/DISCLOSURES
In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer.
The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.
The University of Nevada discloses that all relevant conflicts have been satisfactorily mitigated.